Lee's Pharmaceutical Holdings Ltd
HKEX:950
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lee's Pharmaceutical Holdings Ltd
HKEX:950
|
HK |
|
Triad Group PLC
LSE:TRD
|
UK |
|
Pioneerindo Gourmet International Tbk PT
IDX:PTSP
|
ID |
|
B
|
Bifido Co Ltd
KOSDAQ:238200
|
KR |
|
N
|
Novabase SGPS SA
ELI:NBA
|
PT |
|
C
|
China Bohai Bank Co Ltd
HKEX:9668
|
CN |
Lee's Pharmaceutical Holdings Ltd
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture and sale of pharmaceutical products. The firm operates through two segments. Proprietary Products segment is engaged in the manufacture and sales of self-developed pharmaceutical products. Its proprietary products include Yallaferon, Livaracine and Slounase, among others. Licensed-in Products segment is engaged in the trading of licensed-in pharmaceutical products. Its licensed-in products include Ferplex and Zanidip, among others. The Company’s products are for cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology, among others. The firm mainly operates businesses in China and Hong Kong.
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture and sale of pharmaceutical products. The firm operates through two segments. Proprietary Products segment is engaged in the manufacture and sales of self-developed pharmaceutical products. Its proprietary products include Yallaferon, Livaracine and Slounase, among others. Licensed-in Products segment is engaged in the trading of licensed-in pharmaceutical products. Its licensed-in products include Ferplex and Zanidip, among others. The Company’s products are for cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology, among others. The firm mainly operates businesses in China and Hong Kong.